Evidence map›Paper›PMID 34399957›Full record

ReviewEndocrinology and metabolism clinics of North America2021

Ethnic Disparities in Diabetes.

Nasser Mikhail, Soma Wali, Arleen F Brown

Abstract readReview
In one paragraph

Review in Endocrinology and metabolism clinics of North America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Metabolomic heterogeneity of ageing with ethnic diversity: a step closer to healthy ageing.Metabolomics : Official journal of the Metabolomic Society · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Optimizing Diabetes Care Through Listening to Multiple Voices.Diabetes spectrum : a publication of the American Diabetes Association · 2024
    Article
  16. Article
  17. Hormonal Injustice: Environmental Toxicants as Drivers of Endocrine Health Disparities.Endocrinology and metabolism clinics of North America · 2023
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Nasser MikhailEndocrinology Division, Department of Medicine, Olive View-UCLA Medical Center, David-Geffen-UCLA School of Medicine, Sylmar, CA 91342, USA.
Soma WaliDepartment of Medicine, Olive View-UCLA Medical Center, David-Geffen-UCLA School of Medicine, Sylmar, CA 91342, USA.
Arleen F BrownDepartment of Medicine, Olive View-UCLA Medical Center, David-Geffen-UCLA School of Medicine, Sylmar, CA 91342, USA. Electronic address: abrown@mednet.ucla.edu.
Olive View-UCLA Medical Center · US

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
Stakeholder Engagement Studio CoreU2CDK137135 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI NADIA S ISLAM · 2023 to 2026
$13.4M
The Development and Implementation of a Culturally-Congruent Educational Film designed for PLWHIV to Address Patients' Trauma Histories, Barriers to Care, and CVD Risk ReductionU01HL142109 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BROWN, ARLEEN F., HAMILTON, ALISON B. · 2018 to 2021
$3.8M
Multi-ethnic Multi-level Strategies and Behavioral Economics to Eliminate Hypertension Disparities in LA County.UG3HL154302 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BROWN, ARLEEN F. · 2020 to 2022
$2.7M
Neighborhoods and the Management of Chronic ConditionsK23AG026748 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BROWN, ARLEEN F · 2005 to 2007
$648k
AHRQ HHS F32 HS000132NCATS NIH HHS UL1 TR001881NHLBI NIH HHS U01 HL142109NHLBI NIH HHS UG3 HL154302NIA NIH HHS K23 AG026748NIDDK NIH HHS U2C DK137135
6 · The paper itself

Abstract

Diabetes disproportionably affects minorities in the United States. Substantial disparities exist in diabetes incidence, glycemic control, complications, mortality, and management. The most important biologic contributors to diabetes disparities are obesity, insulin resistance, and inadequate glycemic control. Providers and health systems must also recognize the behavioral, social, and environmental factors that promote and sustain racial/ethnic differences in diabetes and its complications. Metformin and sodium-glucose cotransporter 2 inhibitors are the most convenient drugs for treatment of diabetes in minority patients. Multilevel interventions at the patient, provider, health system, community, and policy levels are needed to reduce diabetes disparities in high-risk groups.

Indexed as

Diabetes MellitusEthnicityHumansIncidenceMinority GroupsObesityUnited StatesDiabetesDisparitiesEthnicityLifestyle changesObesityPreventionTreatment

Identifiers

PMID34399957
PMCPMC13078367
OpenAlexW3181457958

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.